Sandra G. Stoneman Esq. is the Chief Legal Officer, Gen. Counsel & Corp. Sec. at Immunome.
As the Chief Legal Officer a Gen. Counsel & Corp. Sec. of Immunome, the total compensation of Ms Esq at Immunome is $443,432. There are 1 executives at Immunome getting paid more, with Dr. Purnanand Duddu Sarma having the highest compensation of $657,442.
Ms Esq is 48, she's been the Chief Legal Officer a Gen. Counsel & Corp. Sec. of Immunome since . There are 3 older and no younger executives at Immunome. The oldest executive at Immunome, Inc. is Dr. Dennis H. Giesing, 69, who is the Chief Devel. Officer.
Sandra's mailing address filed with the SEC is C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011.
Over the last 4 years, insiders at Immunome have traded over $0 worth of Immunome stock and bought 480,004 units worth $5,722,735 . The most active insiders traders include Clay B Siegall, Jean Jacques Bienaime a Michael Rapp. On average, Immunome executives and independent directors trade stock every 84 days with the average trade being worth of $518,362. The most recent stock trade was executed by Jean Jacques Bienaime on 15 August 2024, trading 7,000 units of IMNM stock currently worth $97,580.
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
Immunome executives and other stock owners filed with the SEC include: